These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6107925)

  • 1. Characterization of opioid receptors in nervous tissue.
    Kosterlitz HW; Paterson SJ
    Proc R Soc Lond B Biol Sci; 1980 Oct; 210(1178):113-22. PubMed ID: 6107925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous opioid peptides: multiple agonists and receptors.
    Lord JA; Waterfield AA; Hughes J; Kosterlitz HW
    Nature; 1977 Jun; 267(5611):495-9. PubMed ID: 195217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors.
    Kosterlitz HW; Lord JA; Paterson SJ; Waterfield AA
    Br J Pharmacol; 1980 Feb; 68(2):333-42. PubMed ID: 6101980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid peptides and their receptors.
    Kosterlitz HW
    Prog Biochem Pharmacol; 1980; 16():3-10. PubMed ID: 6255487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery.
    Brantl V; Pfeiffer A; Herz A; Henschen A; Lottspeich F
    Peptides; 1982; 3(5):793-7. PubMed ID: 6294635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preference of putative pro-enkephalins for different types of opiate receptors.
    Wüster M; Rubini P; Schulz R
    Life Sci; 1981 Sep; 29(12):1219-27. PubMed ID: 6117777
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of p-nitrophenylalanine enkephalins with mu-, delta- and kappa-subtypes of the opiate receptor.
    Fauchère JL; Do KQ; Schwyzer R; Robson LE; Gillan MG; Paterson SJ; Kosterlitz HW
    Eur J Pharmacol; 1982 Feb; 77(4):339-42. PubMed ID: 6277677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific protection of the binding sites of D-Ala2-D-Leu5-enkephalin (delta-receptors) and dihydromorphine (mu-receptors).
    Robson LE; Kosterlitz HW
    Proc R Soc Lond B Biol Sci; 1979 Aug; 205(1160):425-32. PubMed ID: 41257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco mosaic virus-enkephalin conjugates: potentiation of opioid activity.
    Kriwaczek VM; Schwyzer R; Gillan MG; Paterson SJ; Kosterlitz HW
    Peptides; 1981; 2(1):89-92. PubMed ID: 6264412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some aspects of opiate receptors.
    Herz A; Schulz R; Wüster M
    Adv Biochem Psychopharmacol; 1980; 21():329-37. PubMed ID: 6246748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of puromycin on the biological activity of Leu-enkephalin.
    Vogel Z; Altstein M
    FEBS Lett; 1979 Feb; 98(1):44-8. PubMed ID: 218843
    [No Abstract]   [Full Text] [Related]  

  • 13. Opioid activities of beta-casomorphins.
    Brantl V; Teschemacher H; Bläsig J; Henschen A; Lottspeich F
    Life Sci; 1981 Apr; 28(17):1903-9. PubMed ID: 6265721
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and pharmacological evidence for opioid receptor multiplicity in the central nervous system.
    Pasternak GW; Gintzler AR; Houghten RA; Ling GS; Goodman RR; Spiegel K; Nishimura S; Johnson N; Recht LD
    Life Sci; 1983; 33 Suppl 1():167-73. PubMed ID: 6319856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Types of opioid receptors: relation to antinociception.
    Kosterlitz HW; Paterson SJ
    Philos Trans R Soc Lond B Biol Sci; 1985 Feb; 308(1136):291-7. PubMed ID: 2858883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanyl nucleotide interactions with opiate receptors in guinea pig brain and ileum.
    Zukin RS; Gintzler AR
    Brain Res; 1980 Mar; 186(2):486-91. PubMed ID: 6244063
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions of some 4-anilinopiperidines and 4-phenylpiperidines with the mu, delta- and kappa-binding sites.
    Jin WQ; Paterson SJ; Kosterlitz HW; Casy AF
    Life Sci; 1983; 33 Suppl 1():251-3. PubMed ID: 6319871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-directed alkylation of multiple opioid receptors. II. Pharmacological selectivity.
    Goldstein A; James IF
    Mol Pharmacol; 1984 May; 25(3):343-8. PubMed ID: 6328260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.